반려동물 진단 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 동물별, 검사 카테고리별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Companion Animal Diagnostics Market Summary

The global companion animal diagnostics market size was estimated at USD 7.06 billion in 2025 and is projected to reach USD 14.41 billion by 2033, growing at a CAGR of 9.27% from 2026 to 2033. The market is experiencing growth driven by rising pet ownership, increasing spending on advanced veterinary care, and growing awareness of early disease detection.

Key Market Trends & Insights

North America companion animal diagnostics market held the largest revenue share of 37.91% in 2025.The U.S. companion animal diagnostics market is dominated with the largest revenue share in 2025.By product, the consumables, reagents & kits segment held the largest share of 64.96% in the market in 2025By animal type, the dog segment is the largest in the market in 2025.Based on the testing category, the clinical chemistry segment held the largest market share in 2025.

Technological advancements such as point-of-care testing, molecular diagnostics, and AI-based imaging are further accelerating adoption across veterinary clinics worldwide. Moreover, in September 2024, Zoetis introduced the Vetscan OptiCell, an innovative, AI-powered, cartridge-based hematology analyzer designed to provide laboratory-grade complete blood count (CBC) results directly at the point of care. This next-generation diagnostic tool enhances clinical accuracy, streamline workflow efficiency, and features a compact, user-friendly design tailored for veterinary practices. The device is set to make its public debut at the London Vet Show in November 2024.

This cutting-edge innovation is poised to significantly drive growth in the companion animal diagnostics market. By enabling rapid, reliable, and on-site blood analysis, Vetscan OptiCell empowers veterinarians to make faster and more informed treatment decisions. The integration of AI not only boosts diagnostic precision but also reduces the need for outsourced lab services, thereby lowering turnaround time and operational costs. As veterinary clinics and hospitals increasingly seek advanced, easy-to-use diagnostic tools that deliver immediate results, demand for such point-of-care solutions is expected to rise, contributing to broader market expansion. Additionally, the launch strengthens Zoetis' leadership position in veterinary diagnostics, encouraging further innovation and investment in the sector.

Global Companion Animal Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the companion animal diagnostics market report based on product, animal, testing category, end use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Consumables, Reagents & Kits
• Equipment & Instruments
• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Dogs
• Cats
• Horses
• Other Companion Animals
• Testing Category Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical Chemistry
• Microbiology
• Parasitology
• Histopathology
• Cytopathology
• Hematology
• Immunology & Serology
• Imaging
• Molecular Diagnostics
• Other Categories
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Reference Laboratories
• Veterinary Hospitals and Clinics
• Home care settings
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Animal
  • 1.2.3. Testing Category
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Model 1: Bottom-Up Analysis
  • 1.7.2. Model 2: Volume-Pricing Analysis
  • 1.7.3. Model 3: Commodity Flow Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary/Related Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of diseases in animals
    • 3.2.1.2. Increasing animal health expenditure
    • 3.2.1.3. Increasing medicalization rate
    • 3.2.1.4. Increasing humanization of pets
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of standardized regulations
    • 3.2.2.2. Lack of animal health awareness in developing economies
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Pricing Analysis
• 3.4. Market Analysis Tools
  • 3.4.1. Porter's Five Forces Analysis
  • 3.4.2. PESTEL by SWOT Analysis
• 3.5. Estimated Animal Population, by Key Species & Key Countries, 2025

Chapter 4. Companion Animal Diagnostics Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Companion Animal Diagnostics Market, By Product Movement Analysis
• 4.3. Companion Animal Diagnostics Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
• 4.4. Consumables, Reagents & Kits
  • 4.4.1. Consumables, Reagents & Kits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Equipment & Instruments
  • 4.5.1. Equipment & Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Companion Animal Diagnostics Market: Animal Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Companion Animal Diagnostics Market, By Animal Movement Analysis
• 5.3. Companion Animal Diagnostics Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
• 5.4. Dogs
  • 5.4.1. Dogs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Cats
  • 5.5.1. Cats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Horses
  • 5.6.1. Horses Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Others Animals
  • 5.7.1. Others Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Companion Animal Diagnostics Market: By Testing Category Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Companion Animal Diagnostics Market, By Testing Category Movement Analysis
• 6.3. Companion Animal Diagnostics Market Estimates & Forecasts, By Testing Category, 2021 to 2033 (USD Million)
  • 6.3.1. Clinical Chemistry
    • 6.3.1.1. Clinical Chemistry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Microbiology
    • 6.3.2.1. Microbiology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Parasitology
    • 6.3.3.1. Parasitology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.4. Histopathology
    • 6.3.4.1. Histopathology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.5. Cytopathology
    • 6.3.5.1. Cytopathology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.6. Hematology
    • 6.3.6.1. Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.7. Immunology & Serology
    • 6.3.7.1. Immunology & Serology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.8. Imaging
    • 6.3.8.1. Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.9. Molecular Diagnostics
    • 6.3.9.1. Molecular Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.10. Other Categories
    • 6.3.10.1. Other Categories Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Companion Animal Diagnostics Market: By End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Companion Animal Diagnostics Market, By End Use Movement Analysis
• 7.3. Companion Animal Diagnostics Market Estimates & Forecasts, by End Use, 2021 to 2033 (USD Million)
  • 7.3.1. Reference Laboratories
    • 7.3.1.1. Reference Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. Veterinary Hospitals and Clinics
    • 7.3.2.1. Veterinary Hospitals and Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Home care settings
    • 7.3.3.1. Home care settings Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Companion Animal Diagnostics Market: By Regional Estimates & Trend Analysis

• 8.1. Region Market Dashboard
• 8.2. Region Market Share Analysis, 2025 & 2033
• 8.3. North America
  • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. Saudi Arabia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.6. Qatar
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Competitive Scenario
    • 8.7.6.3. Regulatory Framework
    • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.7. Oman
    • 8.7.7.1. Key Country Dynamics
    • 8.7.7.2. Competitive Scenario
    • 8.7.7.3. Regulatory Framework
    • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
• 9.3. Company Profiles
  • 9.3.1. IDEXX Laboratories, Inc.
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product/Service Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Zoetis
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product/Service Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Antech Diagnostics, Inc. (Mars Inc.)
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product/Service Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Agrolabo S.p.A.
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product/Service Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Embark Veterinary, Inc.
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product/Service Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Esaote SPA
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product/Service Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Thermo Fisher Scientific, Inc.
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product/Service Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Innovative Diagnostics SAS
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product/Service Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Virbac
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product/Service Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. FUJIFILM Corporation
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product/Service Benchmarking
    • 9.3.10.4. Strategic Initiatives
• 9.4. List of other key players